Company: LNAI
Filing Date: 2025-10-15
Form Type: DEF 14A
Source: 0001731122-25-001378
Chunk: 64

Company: Lunai Bioworks Inc.
Filing Date: 2025-10-15
Form: DEF 14A
Chunk 64
---
 warrant holders plus any securities that the
individuals included in this table have the right to acquire within 60 days of October 3, 2025 (i) 187,313 shares of our common stock
issuable upon vesting of outstanding restricted stock unitsas of October 3, 2025 ; (ii) warrants to purchase an aggregate 626,983 shares
of our common stock with a weighted average exercise price of $9.09 per share as of October 3, 2025, (iii) options to purchase an aggregate
265,963 of our common stock with a weighted average exercise price of $8.27 per share as of October 3, 2025.

To our
knowledge, except as indicated in the footnotes to this table and pursuant to applicable community property laws, the persons named in
the table have sole voting and investment power with respect to all shares of Common Stock beneficially owned by them. Unless indicated
otherwise, the address for the beneficial holders is c/o Lunai Bioworks Inc. 2080 Century Park E, Suite 906, Los Angeles, CA, U.S.A.

<div align='center'>37</div>

Name of Beneficial Owner

| Named Executive Officers & Directors    |     | Number of Shares(1) |           |     | % Ownership(1) |       |   |
| David Weinstein                         |     |                     |   105,000 |     |                |     * |   |
| Nathen Fuentes                          |     |                     |     9,375 |     |                |     * |   |
| James A. McNulty                        |     |                     |    12,096 |     |                |     * |   |
| Douglas W. Carter                       |     |                     |    12,096 |     |                |     * |   |
| Mark A. Collins, PhD                    |     |                     |    12,096 |     |                |     * |   |
| Directors & Officers Total (5 persons): |     |                     |   150,663 |     |                |  0.63 | % |
| 5% Shareholders:                        |     |                     |           |     |                |       |   |
| PASECO APS (2)                          |     |                     | 1,445,799 |     |                |  6.01 | % |
| Lakysa Ventures, Inc (3)                |